Crossmark

Screening for comorbid autoimmune disease should be considered in children with ANA positive juvenile idiopathic arthritis – results from the south-Swedish juvenile idiopathic arthritis cohort

Crossref DOI link: https://doi.org/10.1186/s12969-024-01030-x

Published Online: 2024-10-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dahlberg, Alma https://orcid.org/0009-0006-6224-6585
Tydén, Helena

Jöud, Anna Saxne

Kahn, Fredrik

Berthold, Elisabet
Funding

Funding for this research was provided by:

Lund University
License Information

Text and Data Mining valid from 2024-10-19

Version of Record valid from 2024-10-19
More Information

Article History

Received: 20 May 2024

Accepted: 14 October 2024

First Online: 19 October 2024

Declarations

:

: The study was approved by the Regional Ethical Review Board for southern Sweden (2011/379, 2013/192 and 2015/62) and the National Ethical Review Agency (2020–02935).

: Not applicable.

: The authors declare that they have no competing interest.

Document is current

Any future updates will be listed below